Top

States Try to Obscure Execution Details as Drugmakers Hinder Lethal Injection

Merck signs $922m deal with Opko Health unit for Epstein-Barr vaccine candidate

After Capping Insulin Copays, Colorado Sets Its Sights on EpiPens

Almond, Soy Drinks Can Be Called Milk, FDA Proposes

GSK and Vir Biotech amend COVID-19 research partnership

Tag: Amylyx ALS drug

FDA, Regulations

FDA extends review of Amylyx ALS drug, delaying approval decision

June 3, 2022

Via: Biopharma Dive

The FDA doesn’t disclose its rationale for extending drug reviews and Amylyx’s statement on the delay offered few details, making it hard to tell how the agency views the company’s application. Two months ago, expert advisers convened by the FDA […]